Preeclampsia and neonatal outcomes in adolescent and adult patients

Ana Veronica Uzunov1, Diana Cristina Secara1,2, Claudia Mehedințu1,3

  • 1Department of Obstetrics and Gynaecology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

Insights

Preeclampsia disproportionately affects adolescents, leading to poorer neonatal outcomes like lower birth weight and increased preterm birth. This study highlights preeclampsia as a significant risk for both adolescent mothers and newborns.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Health
  • Adolescent Medicine

Background:

  • Preeclampsia is a serious pregnancy complication with higher incidence in adolescents.
  • Adolescent pregnancies carry inherent risks, which are exacerbated by preeclampsia.
  • Adverse maternal and neonatal outcomes are linked to preeclampsia and adolescent pregnancies.

Purpose of the Study:

  • To compare neonatal outcomes in adolescent and adult patients with preeclampsia.
  • To investigate the impact of preeclampsia on newborns from adolescent mothers versus adult mothers.

Main Methods:

  • Retrospective analysis of newborns from adolescent mothers with preeclampsia (n=12) and adult mothers with preeclampsia (n=12).
  • Data collected from January 1st, 2019, to December 31st, 2019, at a University Emergency Hospital.
  • Comparison of neonatal outcomes including birth weight, Apgar scores, and delivery type.

Main Results:

  • Preeclampsia prevalence was higher in the adolescent group.
  • Newborns of adolescent mothers with preeclampsia had significantly lower birth weight.
  • Preterm delivery was more frequent in the adolescent preeclampsia group; Apgar scores showed no significant difference.

Conclusions:

  • Preeclampsia presents additional risks for adolescent pregnancies, compounding existing challenges.
  • Adolescent pregnancy combined with preeclampsia leads to poorer neonatal outcomes.
  • Preeclampsia is a severe materno-fetal complication, particularly for the adolescent population.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
27
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
90
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K